
Medical device company STENTiT has appointed Dr Golo von Basum as its Chief Operating Officer.He will be responsible for the …

PhoreMost has announced the appointment of Dr Christian Dillon as Vice President of Biology.In this new role, Dr Dillon will …

Ashfield Engage, part of UDG Healthcare plc, has appointed Serap Becker as Head of Patient Solutions for the DACH region.Joining …

The past decade has seen exponential growth in the field of oncology, with precision medicine at the forefront, driving positive …
Alessandra Dorigo has been appointed as the new General Manager UK, Ireland, Baltics, and Nordics for Novartis Advanced Accelerator Applications …

Drug repurposing is a little like recycling. It is the process of finding new therapeutic uses for drugs that already …

The FDA’s decision to accelerate approval for Aduhelm, the first new drug for Alzheimer’s in two decades, has been met …

Bluebird bio has been granted an innovation passport, under the new UK approval process, for LentiGlobin (bb1111) a promising treatment …

The EU has approved Opdivo (nivolumab) plus Yervoy (ipilimumab) for the treatment of metastatic colorectal cancer. The treatment will be …

Researchers at Chalmers University of Technology in Sweden have announced a breakthrough in the labelling method of messenger RNA (mRNA) …

The EU has approved Merck’s KEYTRUDA, in combination with platinum- and fluoropyrimidine-based chemotherapy, as treatment for advanced oesophageal cancer. The …

CN Bio, an organ-on-a-chip company that designs and manufactures single and multi-organ microphysiological systems (MPS), has announced that their novel …

Incyte and MorphoSys have announced that the EMA’s Committee for Medicinal Products for Human Use (CHMP) has issued a positive …

Quantoom and eTheRNA immunotherapies have announced a strategic collaboration to develop a revolutionary RNA production system (RPS) for both research …

NICE has recommended in draft guidance that girls as young as 12 should be encouraged to do pelvic floor muscle …

A study has shown that Avacta’s AffiDX antigen lateral flow test can detect the Delta variant of COVID-19. The test …

Astellas and FibroGen have announced that the Committee for Medicinal Products for Human Use (CHMP) of the EMA has adopted …

Samsung Bioepis and Biogen have announced that the EMA’s Committee for Medicinal Products for Human Use (CHMP) has adopted a …

Eli Lilly has announced that the SURPASS-2 clinical trial has shown tirzepatide achieved superior HbA1C and body weight reductions compared …

Swiss biopharmaceutical company, Polyphor, has announced that its global Phase III study, FORTRESS, evaluating balixafortide (POL6326) in combination with eribulin …